Photo

Photo detail

Kite Pharma drug Yescarta passed a clinical trial milestone.

Stories this photo appears in:

Kite Partners to Develop Leukemia Treatments

Santa Monica pharmaceutical concern Kite is partnering with HiFiBiO Inc. to develop therapies to treat acute myeloid leukemia.

Tease photo

Kite Cancer Drug Passes a Key Test

Company seeks approval to expand use of Yescarta

Santa Monica pharmaceutical concern Kite Pharma has passed a key clinical trial milestone as it seeks to expand the use of one of its breakthrough drugs to treat a form of non-Hodgkin’s lymphoma cancer.

Tease photo

Kite Adds Production in Europe

HEALTH CARE: Santa Monica-based biopharma to manufacture in Netherlands

The Santa Monica-based Kite pharmaceutical operation has leased a building in the Netherlands to produce its gene-based cancer therapies in Europe, the company announced last week.

Tease photo